Renal cell carcinoma radiofrequency ablation: Evaluation of efficacy based on histological correlation

British Journal of Radiology

Volumn 81, Issue 966, 2008, Pages 479-484

  Mylona, S ^a,b   Ntai, S ^a   Stroumpquli, E ^a   Glentzes, V ^a   Martinis, S ^a   Thanos, L ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b RED CROSS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; RADIOFREQUENCY ABLATION; TUMOR BIOPSY; ULTRASOUND;

ADULT; AGED; CARCINOMA, RENAL CELL; CATHETER ABLATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PREOPERATIVE CARE; RADIOGRAPHY, INTERVENTIONAL; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 46849119002     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/19509680     Document Type: Article

References (43)

1. McLaughlin JK. Epidemiologic aspects of renal cell cancer. Semin Oncol 2003;27:115-23.
2. Moore LE, Wilson RT, Campleman SL. Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest 2005;23:240-55.
3. Hu J, Ugnat AM. Active and passive smoking and risk of renal cell carcinoma in Canada. Eur J Cancer 2005;41:770-8.
4. Kiuru M, Kujala M, Aitommaki K. Inherited forms of renal cell carcinoma. Scand J Surg 2004;93:103-11.
5. Lee CT, Katz J, Fearn PA, Russo P. Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol 2002;4:135-40.
6. Novick AC, Derweesh I. Open partial nephrectomy for renal tumours: current status. Br J Urol 2005;95 (Suppl 2): 35-40.
7. Galli B, Munver R, Sawczuk I, Kochis E. Laparoscopic radical nephrectomy in renal cell carcinoma. Urol Nurs 2005;25:83-6, 133, quiz:87
8. Lee BR. Laparoscopic total and partial nephrectomy. Int Braz J Urol 2002;28:504-9.
9. Ono Y, Hattori R, Gotoh M, Yoshino Y, Yoshikawa Y, Kamihira O. Laparoscopic radical nephrectomy for renal cell carcinoma: the standard of care already? Curr Opin Urol 2005;15:75-8.
10. Mahnken AH, Gunther RW, Tacke J. Radiofrequency ablation of renal tumors. Eur Radiol 2004;14:1449-55.
11. Ukimura O, Kawauchi A, Fujito A, Mizutani Y, Okihara K, Mikami K, et al. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk. Int J Urol 2004;11:1051-7.
12. Hwang JJ, Walther MM, Pautler SE, Coleman JA, Hvizda J, Peterson J, et al. Radio frequency ablation of small renal tumors: intermediate results. J Urol 2004;171:1814-18.
13. Su LM, Jarrett TW, Chan DY, Kavoussi LR, Solomon SB. Percutaneous computed tomography-guided radiofre-quency ablation of renal masses in high surgical risk patients: preliminary results. Urology 2003;61:26-33.
14. Gill IS, Remer EM, Hasan WA, Strzempkowski B, Spaliviero M, Steinberg AP, et al. Renal cryoablation: outcome at 3 years. J Urol 2005;173:1903-7.
15. Sewell PE, Howard JC, Shingleton WB, Harrison RB. Interventional magnetic resonance image-guided percutaneous cryoablation of renal tumors. South Med J 2003;96:708-10.
16. Lee DI, Clayman RV. Percutaneous approaches to renal cryoablation. J Endourol 2004;18:643-6.
17. Cestari A, Guazzoni G, dell'Acqua V, Nava L, Cardone G, Balconi G, et al. Laparoscopic cryoablation of solid renal masses: intermediate term followup. J Urol 2004;172:1267-70.
18. Morgan JH 3rd, Royer GM, Hackett P, Gamblin TC, McCampbell BL, Conforti A, et al. Radio-frequency ablation of large, nonresectable hepatic tumors. Am Surg 2004;70:1035-8.
19. Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 2005;12:616-28.
20. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, et al. Percutaneous radiofrequency ablation of hepatocel-lular carcinoma as a bridge to liver transplantation. Hepatology 2005;41:1130-7.
21. Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159-66.
22. Thanos L, Mylona S, Pomoni M, Kalioras V, Zoganas L, Batakis N. Primary lung cancer: treatment with radiofrequency thermal ablation. Eur Radiol 2004;14:897-901.
23. Gadaleta C, Catino A, Ranieri G, Armenise F, Colucci G, Lorusso V, et al. Radiofrequency thermal ablation of 69 lung neoplasms. J Chemother 2004;16:86-9.
24. Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003;97:554-60.
25. Jindal G, Friedman M, Locklin J, Wood BJ. Palliative radiofrequency ablation for recurrent prostate cancer. Cardiovasc Intervent Radiol 2006;29:482-5.
26. Marcy PY, Magne N, Castadot P, Bailet C, Namer M. Ultrasound-guided percutaneous radiofrequency ablation in elderly breast cancer patients: preliminary institutional experience. Br J Radiol 2007;80:267-73.
27. Callstrom MR, Charboneau JW, Goetz MP, Rubin J, Wong GY, Sloan JA, et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radiofrequency ablation. Radiology 2002;224:87-97.
28. Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004;22:300-6.
29. Jakobs TF, Hoffmann RT, Vick C, Wallnofer A, Reiser MF, Helmberger TK. RFA of bone and soft tissue tumors. Radiologe 2004;44:370-5.
30. Anderson JK, Shingleton WB, Cadeddu JA. Imaging associated with percutaneous and intraoperative management of renal tumors. Urol Clin North Am 2006;33:339-52.
31. Matlaga BR, Zagoria RJ, Woodruff RD, Torti FM, Hall MC. Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J Urol 2002;168:2411-12.
32. Matsumoto ED, Watumull L, Johnson DB, Ogan K, Taylor GD, Josephs S, et al. The radiographic evolution of radio frequency ablated renal tumors. J Urol. 2004;172:45-8.
33. Boss A, Martirosian P, Schraml C, Clasen S, Fenchel M, Anastasiadis A, et al. Morphological, contrast-enhanced and spin labeling perfusion imaging for monitoring of relapse after RF ablation of renal cell carcinomas. Eur Radiol 2006;16:1226-36.
34. Svatek RS, Sims R, Anderson JK, Abdel-Aziz K, Cadeddu JA. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation. Urology 2006;67:508-12.
35. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003;226:417-24.
36. Zagoria RJ, Hawkins AD, Clark PE, Hall MC, Matlaga BR, Dyer RB, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol 2004;183:201-7.
37. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: technique and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003;180:1503-8.
38. Lu DSK, Raman SS, Limanond P, Aziz D, Economou J, Busuttil R, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003;14:1267-74.
39. Bastide C, Garcia S, Anfossi E, Ragni E, Rossi D. Histologic evaluation of radiofrequency ablation in renal cancer. Eur J Surg Oncol 2006;32:980-3.
40. Matlaga BR, Zagoria RJ, Woodruff RD, Torti FM, Hall MC. Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J Urol 2002;168:2401-5.
41. Stern JM, Anderson JK, Lotan Y, Park S, Cadeddu JA. Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors: is a positive stain synonymous with ablative failure? J Urol 2006;176:1969-72, discussion: 1972
42. Anderson JK, Baker M, Jaffers O, Pearle MS, Lindberg GL, Cadeddu JA. Time course of nicotinamide adenine dinu-cleotide diaphorase staining after renal radiofrequency ablation influences viability assessment. J Endourol 2007;21:223-7.
43. Marcovich R, Aldana JP, Morgenstern N, Jacobson AI, Smith AD, Lee BR. Optimal lesion assessment following acute radio frequency ablation of porcine kidney: cellular viability or histopathology? J Urol 2003;170:1370-4.